| Dr William Brian O'grady, MD | |
|
707 Main St, Toms River, NJ 08753-6517 | |
| (732) 244-2666 | |
| (732) 286-7040 |
| Full Name | Dr William Brian O'grady |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Location | 707 Main St, Toms River, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063514610 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MAO24172 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Brian O'grady, MD 644 Oceanview Rd, Brielle, NJ 08730-1221 Ph: (732) 528-0765 | Dr William Brian O'grady, MD 707 Main St, Toms River, NJ 08753-6517 Ph: (732) 244-2666 |
News Archive
A rarely prescribed asthma drug is easier to use and just as effective as conventional treatment with inhalers, according to a new study led by the University of East Anglia.
BARRX Medical Inc., a leader in the development of minimally invasive medical devices designed to remove precancerous tissue from within the gastrointestinal tract, reported today that the Society of American Gastrointestinal and Endoscopic Surgeons has issued a new practice guideline for the surgical treatment of gastroesophageal reflux disease. Left untreated, reflux of stomach contents such as acid and bile into the esophagus in GERD patients often leads to injury and chronic inflammation of the lining of the esophagus.
Hospitals that make greater use of inpatient diagnostic imaging exams achieve lower in-hospital mortality rates with little or no impact on costs, according to a peer-reviewed study of more than 1 million patient outcomes in more than 100 hospitals nationwide published in the November issue of the Journal of the American College of Radiology (JACR).
A team of researchers from Arizona State University and Mayo Clinic is showing how a staple of Earth science research can be used in biomedical settings to predict the course of disease.
Mirati Therapeutics, Inc. today presented data that demonstrated preliminary evidence of clinical activity from its investigational targeted tyrosine kinase inhibitor candidate, MGCD265, as part of the developmental therapeutics category at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago from May 29-June 2, 2015.
› Verified 2 days ago
Dr. Robert Mark Rosen, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 780 Route 37 W, Ste 240, Toms River, NJ 08755 Phone: 732-244-4566 Fax: 732-569-6285 | |
Sunita Borade, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1580 Lakewood Rd Ste 16a, Toms River, NJ 08755 Phone: 732-966-5493 | |
Robert Lee, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3 Plaza Dr Ste 17, Toms River, NJ 08757 Phone: 732-934-4141 Fax: 732-442-8886 | |
Dr. Sal T Laforgia, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 780 Route 37 W Ste 235, Toms River, NJ 08755 Phone: 732-557-9300 | |
Dr. Melissa K Dixon, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 111 W Water St, Toms River, NJ 08753 Phone: 732-244-4700 Fax: 732-244-2804 | |
Dr. Asma Iram Ahmed, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 111 W Water St, Toms River, NJ 08753 Phone: 800-337-6663 |